Highlights: Key Opinion Leader Event on Bone Marrow Transplant, Potential Role of Iomab-B
Highlights Segment from Bone Marrow Transplantation and Radioimmunotherapy
Phase III Drug Candidate: Iomab-B
Hillard Lazarus MD, Professor of Medicine at Case Western Reserve University
Roland Turck MD, Radiopharmaceutical Veteran with Extensive Drug Commercialization Experience